Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 28 (1-2) , 20-48
- https://doi.org/10.1080/08830180802684331
Abstract
To date, most HIV vaccine strategies have focused on parenteral immunization and systemic immunity. These approaches have not yielded the efficacious HIV vaccine urgently needed to control the AIDS pandemic. As HIV is primarily mucosally transmitted, efforts are being re-focused on mucosal vaccine strategies, in spite of complexities of immune response induction and evaluation. Here, we outline issues in mucosal vaccine design and illustrate strategies with examples from the recent literature. Development of a successful HIV vaccine will require in-depth understanding of the mucosal immune system, knowledge that ultimately will benefit vaccine design for all mucosally transmitted infectious agents.Keywords
This publication has 161 references indexed in Scilit:
- Orchestrating the orchestrators: chemokines in control of T cell trafficNature Immunology, 2008
- Critical issues in mucosal immunity for HIV-1 vaccine developmentJournal of Allergy and Clinical Immunology, 2008
- Dendritic cells in intestinal immune regulationNature Reviews Immunology, 2008
- Setting the stage: host invasion by HIVNature Reviews Immunology, 2008
- Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicProceedings of the National Academy of Sciences, 2008
- Sublingual vaccination with influenza virus protects mice against lethal viral infectionProceedings of the National Academy of Sciences, 2008
- Replicating and non-replicating viral vectors for vaccine developmentCurrent Opinion in Biotechnology, 2007
- Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsulesVaccine, 2007
- Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeysVaccine, 2007
- Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1Immunity, 2007